Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation (Q33389485)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation |
scientific article |
Statements
1 reference
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation (English)
1 reference
Guido Marcucci
1 reference
John C Byrd
1 reference
Christoph Plass
1 reference
Michael R Grever
1 reference
Kristie A Blum
1 reference
Zhiliang Xie
1 reference
Robert Baiocchi
1 reference
Steven M Devine
1 reference
Leslie Andritsos
1 reference
Jeffrey Jones
1 reference
Zhongfa Liu
1 reference
David M Lucas
1 reference
Ping Chen
1 reference
Donald M Benson
1 reference
Joseph Flynn
1 reference
Kenneth K Chan
1 reference
1 reference
Identifiers
1 reference